Evidence map›Paper›PMID 30801995›Full record

ReviewInfluenza and other respiratory viruses2019

Influenza surveillance in Middle East, North, East and South Africa: Report of the 8th MENA Influenza Stakeholders Network.

Suleiman Abusrewil, Abdulrahman Algeer, Alanoud Aljifri, Fatima Al Slail, Melissa K Andrew, Mohamed Awad Tag Eldin, Salah Al Awaidy, Nissaf Ben Alaya, Jalila Ben Khelil, Ghassan Dbaibo and 18 more

Abstract readReview
In one paragraph

Review in Influenza and other respiratory viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Suleiman AbusrewilMedical school Tripoli university, Tripoli, Libya.
Abdulrahman AlgeerMedical services directorate of the armed forces/Ministry of defense, Riyadh, Saudi Arabia.
Alanoud AljifriMinistry of Health, Riyadh, Saudi Arabia.
Fatima Al SlailMinistry of Health, Riyadh, Saudi Arabia.
Melissa K AndrewDalhousie University and Canadian Centre for Vaccinology, Halifax, Canada.
Mohamed Awad Tag EldinMinistry of Health, Cairo, Egypt.
Salah Al AwaidyMinistry of Health, Mascate, Oman.
Nissaf Ben AlayaMinistry of Health, Tunis, Tunisia.
Jalila Ben KhelilHopital Abderrahmene Mami, Tunis, Tunisia.
Ghassan DbaiboAmerican University of Beirut, Beirut, Lebanon.
Fawzi DerrarInstitut Pasteur d'Algerie, Algiers, Algeria.
Omar ElahmerNational Centre for Disease Control, Tripoli, Libya.
Nada GhosnMinistry of Public Health, Beirut, Lebanon.
Guelsah GabrielHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Cindy GrassoFondation Mérieux, Lyon, France.
Mohamed HassanMinistry of Health and Prevention, Abou Dabi, United Arab Emirates.
Siddhivinayak HirveWorld Health Organisation, Geneva, Switzerland.
Yusuf Kamal MirzaAgha khan university, Karachi, Pakistan.
Yousef Moh'd RatebMinistry of Health, Amman, Jordan.
Jalal NourlilInstitut Pasteur du Maroc, Casablanca, Morocco.
Marta C NunesFaculty of Health Science, Department of Science/National Research Foundation: Vaccine Preventable Diseases Unit, Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Idris OmaimaFaculty of Medicine, Cairo University, Cairo, Egypt.
Oliver Ombeva MalandeEgerton University, Nakuru, Kenya & East Africa Centre for Vaccines and Immunization (ECAVI), Egerton, Kenya.
Mitra Saadatian-ElahiEdouard Herriot Hospital, Lyon, France.ORCID 0000-0003-1265-8806
Valentina Sanchez-PicotFondation Mérieux, Lyon, France.
Malik Sk Mamunur RahmanWorld Health Organization Eastern Mediterranean Regional Office, Cairo, Egypt.
Hesham TarrafFaculty of Medicine, Cairo University, Cairo, Egypt.
Sibongile WalazaNational Institute of Communicable Disease (NICD), Johannesburg, South Africa.ORCID 0000-0001-7588-2480

Funding

World Health Organization 001
6 · The paper itself

Abstract

The Middle-East and Africa Influenza Surveillance Network (MENA-ISN), established in 2014, includes 15 countries at present. Country representatives presented their influenza surveillance programmes, vaccine coverage and influenza control actions achieved, and provided a list of country surveillance/control objectives for the upcoming 3 years. This report details the current situation of influenza surveillance and action plans to move forward in MENA-ISN countries. Data were presented at the 8th MENA-ISN meeting, organized by the Mérieux Foundation that was held on 10-11 April 2018 in Cairo, Egypt. The meeting included MENA-ISN representatives from 12 countries (Algeria, Egypt, Jordan, Kenya, Lebanon, Libya, Morocco, Pakistan, Saudi Arabia, South Africa, Tunisia and United Arab Emirates) and experts from the Canadian Centre for Vaccinology, and the World Health Organization. Meeting participants concluded that influenza remains a significant threat especially in high-risk groups (children under-5, elderly, pregnant women and immunosuppressed individuals) in the MENA-ISN region. Additional funding and planning are required by member countries to contain this threat. Future meetings will need to focus on creative and innovative ways to inform policy and initiatives for vaccination, surveillance and management of influenza-related morbidity and mortality especially among the most vulnerable groups of the population.

Indexed as

Epidemiological MonitoringAfricaCommunicable Disease ControlDisease Transmission, InfectiousHumansInfluenza, HumanInfluenza VaccinesInternational CooperationMiddle EastVaccination CoverageInfluenza VaccinesinfluenzaMENA-ISNMiddle EastNorth, East and South Africasurveillancevaccination coverage

Identifiers

PMID30801995
PMCPMC6468068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.